Cardiology

  • Pseudo-Wellens syndrome after heavy marijuana use
    Michael Lawrenz Ferreras Co, MD, Anshuman Das, MD and Tochukwu Okwuosa, DO
    Cleveland Clinic Journal of Medicine August 2017, 84 (8) 590-591; DOI: https://doi.org/10.3949/ccjm.84a.16133

    Acute marijuana intoxication is associated with reversible changes in the P and T waves and ST segments.

  • Delirium in hospitalized patients: Risks and benefits of antipsychotics
    Robyn Pauline Thom, MD, Clare Kelleher Mock, MD and Polina Teslyar, MD
    Cleveland Clinic Journal of Medicine August 2017, 84 (8) 616-622; DOI: https://doi.org/10.3949/ccjm.84a.16077

    No drug is approved for delirium, but antipsychotics can be used in certain situations.

  • Anticoagulation for atrial fibrillation (January 2017)
    Elise Henning, MD, MED
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 658; DOI: https://doi.org/10.3949/ccjm.84c.09001

    Readers comment on anticoagulation for atrial fibrillation (January 2017).

  • In reply: Anticoagulation for atrial fibrillation (January 2017)
    Theodore T Suh, MD, PhD, MHS, AGSF
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 658-659; DOI: https://doi.org/10.3949/ccjm.84c.09002
  • Cardiac mass: Tumor or thrombus? (July 2017)
    Mahmoud Abdelghany, MD, Moustafa Elsheshtawy, MD and Hani Kozman, MD
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 659; DOI: https://doi.org/10.3949/ccjm.84c.09003

    Readers comment on cardiac masses (July 2017).

  • Heartburn or heart attack? A mimic of MI
    Willis S. Bowman, MD, Amir Farid, MD and Paul Aronowitz, MD
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 664-665; DOI: https://doi.org/10.3949/ccjm.84a.16093

    The diagnosis: milk-alkali syndrome, complicated by thiazide use.

  • Renal denervation: What happened, and why?
    Mehdi H. Shishehbor, DO, MPH, PhD, Tarek A. Hammad, MD and George Thomas, MD, MPH
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 681-686; DOI: https://doi.org/10.3949/ccjm.84a.14129

    Despite promising initial results, this treatment failed in its largest trial to date. Is it dead? Can it be revived?

  • Renal denervation: Are we on the right path?
    Ali E. Denktas, MD, FACC, FSCAI, David Paniagua, MD, FACC, FSCAI and Hani Jneid, MD, FACC, FAHA, FSCAI
    Cleveland Clinic Journal of Medicine September 2017, 84 (9) 687-689; DOI: https://doi.org/10.3949/ccjm.84a.17024

    Before renal denervation can be a mainstream therapy, we need proof that it reduces blood pressure or clinical events.

  • Is it time to abandon fasting for routine lipid testing?
    Zareen Farukhi, MD and Samia Mora, MD, MHS
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 919-922; DOI: https://doi.org/10.3949/ccjm.84a.16135

    Yes. Most patients do not need to fast.

  • Diagnosis and treatment of hyperkalemia
    Diagnosis and treatment of hyperkalemia
    Biff F. Palmer, MD and Deborah J. Clegg, PhD
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 934-942; DOI: https://doi.org/10.3949/ccjm.84a.17056

    It is most common in patients with renal impairment, can be life-threatening, and requires a multidisciplinary approach.

Pages